Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19-infection”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04952857
What this trial is testing

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

Who this might be right for
Covid19
Post Graduate Institute of Medical Education and Research, Chandigarh 90
Large-scale testing (Phase 3)Ended earlyNCT04523090
What this trial is testing

Catalysing the Containment of COVID-19

Who this might be right for
COVID-19
University of Cape Town 322
Large-scale testing (Phase 3)Study completedNCT04486313
What this trial is testing

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Who this might be right for
COVID-19
Romark Laboratories L.C. 935
Very early researchStudy completedNCT04412486
What this trial is testing

COVID-19 Convalescent Plasma (CCP) Transfusion

Who this might be right for
COVID-19
Gailen D. Marshall Jr., MD PhD 86
Not applicableStudy completedNCT04527562
What this trial is testing

Colchicine in Moderate Symptomatic COVID-19 Patients

Who this might be right for
Covid19
Dhaka Medical College 299
Testing effectiveness (Phase 2)Study completedNCT04900337
What this trial is testing

Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.

Who this might be right for
Covid19
Amorphical Ltd. 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07664696
What this trial is testing

Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms

Who this might be right for
COVID-19
Kimera Labs Inc. 64
Early research (Phase 1)UnknownNCT05083000
What this trial is testing

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Who this might be right for
COVID-19 Respiratory Infection
National University Hospital, Singapore 24
Testing effectiveness (Phase 2)Ended earlyNCT04498377
What this trial is testing

Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
EVIVE Biotechnology 1
Not applicableStudy completedNCT04621903
What this trial is testing

A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19

Who this might be right for
Covid19
Aarogyam UK 26
Testing effectiveness (Phase 2)Looking for participantsNCT07157007
What this trial is testing

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID - 19
Traws Pharma, Inc. 90
Early research (Phase 1)Ended earlyNCT05184218
What this trial is testing

Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19

Who this might be right for
Healthy VolunteersCOVID-19
IGM Biosciences, Inc. 26
Large-scale testing (Phase 3)UnknownNCT04467918
What this trial is testing

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms

Who this might be right for
SARS-CoV2
University of Sao Paulo 100
Not applicableStudy completedNCT04681079
What this trial is testing

Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19

Who this might be right for
COVID-19
Theravance Biopharma 14
Not applicableStudy completedNCT04486482
What this trial is testing

A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

Who this might be right for
Mild-to-Moderate COVID-19
Kaleido Biosciences 49
Testing effectiveness (Phase 2)Study completedNCT04347915
What this trial is testing

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

Who this might be right for
COVID-19
Bukwang Pharmaceutical 64
Testing effectiveness (Phase 2)Ended earlyNCT05381363
What this trial is testing

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

Who this might be right for
COVID-19Children
Children's Hospital of Fudan University 24
Not applicableStudy completedNCT04927182
What this trial is testing

Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.

Who this might be right for
Covid19
Riphah International University 102
Early research (Phase 1)Study completedNCT04633980
What this trial is testing

Hydrogen Therapy in Patients With Moderate Covid-19

Who this might be right for
Covid-19
University Hospital, Grenoble 12
Not applicableUnknownNCT05665205
What this trial is testing

Benefits of an Aerobic and Strength Rehabilitation Program With Post- SARS-CoV-2 Patients Moderate-severe

Who this might be right for
COVID-19
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation